Suven Life Science profits on obtaining Suven Pharmaceuticals by admin- Wednesday, February 6th, 2019 04:55:50 PM
Suven Life Sciences is currently trading at Rs. 206.10, up by way of 0.55 factors or 0.27% from its previous closing of Rs. 205.55 at the BSE.
The scrip opened at Rs. 202.40 and has touched a excessive and coffee of Rs. 211.45 and Rs. 202.Forty respectively. So some distance 28877 stocks were traded on the counter.
The BSE organization ‘B’ stock of face fee Rs. 1 has touched a fifty two week excessive of Rs. 337.70 on 11-Sep-2018 and a 52 week low of Rs. 163.30 on 23-Mar-2018.
Last one week high and coffee of the scrip stood at Rs. 211.45 and Rs. 188.40 respectively. The current market cap of the enterprise is Rs. 2616.29 crore.
The promoters conserving within the company stood at 60.00%, at the same time as Institutions and Non-Institutions held eight.48% and 31.Fifty two% respectively.
Suven Life Science has obtained all the stocks of Suven Pharmaceuticals (SPL), a public restrained employer, from its current shareholders. Pursuant to which, Suven Pharmaceuticals has become a completely owned subsidiary of the organisation. The board of administrators at their conferences hung on February 5, 2019 accepted the equal. The Board also authorised draft Scheme of Arrangement to be filed at the National Company Law Tribunal bench at Hyderabad, for essential approvals.